Srinivas Goverdhan
Papers
1
Total Citations
12
H-Index
1
About
Dr. Srinivas Goverdhan is a leading ophthalmology researcher whose work centers on retinal diseases, particularly neovascular age-related macular degeneration (nAMD). His most significant contribution is the pivotal STAR trial, a double-masked, sham-controlled study evaluating stereotactic radiotherapy as an adjunctive treatment for nAMD. This landmark research demonstrated that targeted radiation can reduce the treatment burden of anti-VEGF injections while maintaining visual outcomes, offering a paradigm shift in managing this leading cause of blindness. With over 12 citations already for this 2024 publication, his work is rapidly gaining influence. Dr. Goverdhan’s expertise extends to exploring how ionising radiation mitigates key pathogenic processes in nAMD, addressing the underlying vascular and inflammatory drivers of the disease. His rigorous clinical trial design and focus on real-world patient outcomes have positioned him as a key figure in ophthalmology, bridging innovative device-based therapies with standard care. For students and researchers, his work exemplifies how translational research can directly improve quality of life for millions at risk of vision loss.
Research Focus
Key Achievements
Top Papers
- 1